Imexpharm Corporation (HOSE: IMP)

Imexpharm Market Cap

Imexpharm has a market cap or net worth of 7.44 trillion as of December 20, 2024. Its market cap has increased by 93.20% in one year.

• Market Cap: 7.44T
• Enterprise Value: 7.27T
• Revenue: 2.16T
• Ranking: n/a
• PE Ratio: 32.40
• Stock Price: 48,300.00

Market Cap Chart

Since April 2, 2007, Imexpharm's market cap has increased from 1.11T to 7.44T, an increase of 570.87%. That is a compound annual growth rate of 11.33%.

Market Cap History

Date	Market Cap	% Change
Dec 20, 2024	7,438.63B	87.74%
Dec 29, 2023	3,962.17B	-1.28%
Dec 30, 2022	4,013.63B	-22.62%
Dec 31, 2021	5,187.05B	38.19%
Dec 31, 2020	3,753.61B	58.34%
Dec 31, 2019	2,370.59B	-21.20%